As health care delivery in the United States continues its transformation from an open, fee-for-service system into one dominated by capitation and the constraints of managed care, decisions about the availability of health services will be based increasingly on the results of medical outcome studies and cost-effectiveness analyses. There are few groups of patients for whom such decisions will have larger medical and economic impact then patients with osteoarthritis (OA). Moreover, given the tendency of medical outcomes studies to define health operationally as health-related functional status, few groups of patients will be more poorly served by such a bias than patients with OA--for whom relief of joint pain is paramount.
The specific aims of this project will be (1) to establish a clinical routine for outpatient care of OA in which joint pain is monitored and charted as a vital sign in the medical record by an allied health professional and (2) to document the effects of longitudinal charting of such information on doctor-patient communication about pain, pain management practices of physicians, and patient outcomes (pain, satisfaction, and cost). We will utilize the practices of 9 rheumatologists (6 university- and 3 community-based) and a total of 90 patients with OA of the knee (10 patients/practice) in the study. For three consecutive office visits, each patient will undergo a pre- encounter assessment consisting of a validated measure of knee pain [the Western Ontario and McMaster Universities (WOMAC) OA Index], and ad hoc questionnaire measuring the patient's satisfaction with current control of joint pain, and a review of costs for arthritis drugs (NSAIDs, analgesics, anti-peptic-ulcer medications) since the last office visit. Following each office visit, a post-encounter interview will be held in which we will document any discussion of knee pain that took place between the patient and physician, any changes in prescription or over- the-counter (OTC) medications for knee OA, and the initiation of nonpharmacologic treatment (physical therapy, quadriceps-strengthening exercises, thermal modalities). Using a randomization scheme stratified for practice setting (university vs. community), the 9 rheumatologists (each with his or her cohort of 10 patients) will be assigned to one of three conditions: Pain-Charting (PC), cost-Monitoring (CM0, and pure control (CON). Under the PC condition, a graph will be appended to each patient's office record that will provide for the charting from visit to visit of WOMAC Pain scores [range: 5 (none) to 25 (extreme)] and the patient's concurrent satisfaction with control of knee pain. While it will have considerable intrinsic interest, the primary purpose of the CM group will be to serve as an attention-control condition. In the CM condition, a table containing a tally of the cumulative total and out-of- pocket costs to the patient for their OA drugs (NSAIDs, analgesics, anti- peptic ulcer drugs) will be appended to each patient's record. CON patients will receive the same pre- and post-encounter assessments as PC and CM patients, but no information will be brought to the attention of the physician for use during the visit. After the 10 patients in each practice have completed 3 office visits under their assigned condition PC, CM or CON), longitudinal and between-group comparisons will determine the effects of interventions on the frequency of doctor-patient communication about pain management, the prescribing practices of rheumatologists, and patient outcomes: joint pain, NSAID-induced side effects, satisfaction, and (controlling for medical insurance co-payment status) the cost of OA drugs.

Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1996
Total Cost
Indirect Cost
Merle-Vincent, F; Vignon, E; Brandt, K et al. (2007) Superiority of the Lyon schuss view over the standing anteroposterior view for detecting joint space narrowing, especially in the lateral tibiofemoral compartment, in early knee osteoarthritis. Ann Rheum Dis 66:747-53
Otterness, Ivan G; Brandt, Kenneth D; Le Graverand, Marie-Pierre Hellio et al. (2007) Urinary TIINE concentrations in a randomized controlled trial of doxycycline in knee osteoarthritis: implications of the lack of association between TIINE levels and joint space narrowing. Arthritis Rheum 56:3644-9
Mazzuca, Steven A; Brandt, Kenneth D; Katz, Barry P et al. (2007) Risk factors for early radiographic changes of tibiofemoral osteoarthritis. Ann Rheum Dis 66:394-9
Mazzuca, S A; Brandt, K D; Eyre, D R et al. (2006) Urinary levels of type II collagen C-telopeptide crosslink are unrelated to joint space narrowing in patients with knee osteoarthritis. Ann Rheum Dis 65:1055-9
Brandt, Kenneth D; Mazzuca, Steven A (2006) Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial. Rheum Dis Clin North Am 32:217-34, xi-xii
Mazzuca, S A; Brandt, K D; Katz, B P et al. (2006) Comparison of quantitative and semiquantitative indicators of joint space narrowing in subjects with knee osteoarthritis. Ann Rheum Dis 65:64-8
Mazzuca, Steven A; Poole, A Robin; Brandt, Kenneth D et al. (2006) Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. J Rheumatol 33:1147-51
Mikesky, Alan E; Mazzuca, Steven A; Brandt, Kenneth D et al. (2006) Effects of strength training on the incidence and progression of knee osteoarthritis. Arthritis Rheum 55:690-9
Hellio Le Graverand, M-P; Brandt, K D; Mazzuca, S A et al. (2006) Association between concentrations of urinary type II collagen neoepitope (uTIINE) and joint space narrowing in patients with knee osteoarthritis. Osteoarthritis Cartilage 14:1189-95
Brandt, Kenneth D; Mazzuca, Steven A; Katz, Barry P et al. (2005) Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trial. Arthritis Rheum 52:2015-25

Showing the most recent 10 out of 162 publications